[
  {
    "ts": null,
    "headline": "Which S&P500 stocks are moving on Thursday?",
    "summary": "Let's delve into the developments on the US markets in the middle of the day on Thursday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.",
    "url": "https://finnhub.io/api/news?id=a8261fc93581f4b82ed25f3e8b473e76eb90ecb1d52ee4d69491f215cd88670e",
    "source": "ChartMill",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771522508,
      "headline": "Which S&P500 stocks are moving on Thursday?",
      "id": 139150240,
      "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
      "related": "PODD",
      "source": "ChartMill",
      "summary": "Let's delve into the developments on the US markets in the middle of the day on Thursday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.",
      "url": "https://finnhub.io/api/news?id=a8261fc93581f4b82ed25f3e8b473e76eb90ecb1d52ee4d69491f215cd88670e"
    }
  },
  {
    "ts": null,
    "headline": "Citigroup Maintains Buy on Insulet, Lowers Price Target to $345",
    "summary": "Citigroup  analyst Joanne Wuensch   maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price target from $380 to $345.",
    "url": "https://finnhub.io/api/news?id=9b70a71eadd740ce26e37fdca930fe39c08fc4ec1aabc314b289f69fa0f4f0ee",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771516353,
      "headline": "Citigroup Maintains Buy on Insulet, Lowers Price Target to $345",
      "id": 139158817,
      "image": "",
      "related": "PODD",
      "source": "Benzinga",
      "summary": "Citigroup  analyst Joanne Wuensch   maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price target from $380 to $345.",
      "url": "https://finnhub.io/api/news?id=9b70a71eadd740ce26e37fdca930fe39c08fc4ec1aabc314b289f69fa0f4f0ee"
    }
  },
  {
    "ts": null,
    "headline": "Truist Securities Maintains Buy on Insulet, Lowers Price Target to $360",
    "summary": "Truist Securities  analyst Richard Newitter   maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price target from $390 to $360.",
    "url": "https://finnhub.io/api/news?id=0b39bd3078b192957940b23f2d1176780a70ab09abbe295484a33a9e23ab241e",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771509705,
      "headline": "Truist Securities Maintains Buy on Insulet, Lowers Price Target to $360",
      "id": 139158818,
      "image": "",
      "related": "PODD",
      "source": "Benzinga",
      "summary": "Truist Securities  analyst Richard Newitter   maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price target from $390 to $360.",
      "url": "https://finnhub.io/api/news?id=0b39bd3078b192957940b23f2d1176780a70ab09abbe295484a33a9e23ab241e"
    }
  },
  {
    "ts": null,
    "headline": "Goldman Sachs Maintains Buy on Insulet, Lowers Price Target to $326",
    "summary": "Goldman Sachs  analyst David Roman   maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price target from $363 to $326.",
    "url": "https://finnhub.io/api/news?id=55b1937cd51257036ebf018fca7b5c95fc3a41d097149208ba8dbb663520cabe",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771508505,
      "headline": "Goldman Sachs Maintains Buy on Insulet, Lowers Price Target to $326",
      "id": 139158819,
      "image": "",
      "related": "PODD",
      "source": "Benzinga",
      "summary": "Goldman Sachs  analyst David Roman   maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price target from $363 to $326.",
      "url": "https://finnhub.io/api/news?id=55b1937cd51257036ebf018fca7b5c95fc3a41d097149208ba8dbb663520cabe"
    }
  },
  {
    "ts": null,
    "headline": "Bernstein Maintains Outperform on Insulet, Lowers Price Target to $330",
    "summary": "Bernstein  analyst Lee Hambright   maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the price target from $380 to $330.",
    "url": "https://finnhub.io/api/news?id=c6194bf4119ad3f6da8d4c798c96ff24ef19ebd546eb2d29f69377c0ae3bdc7b",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771507948,
      "headline": "Bernstein Maintains Outperform on Insulet, Lowers Price Target to $330",
      "id": 139158820,
      "image": "",
      "related": "PODD",
      "source": "Benzinga",
      "summary": "Bernstein  analyst Lee Hambright   maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the price target from $380 to $330.",
      "url": "https://finnhub.io/api/news?id=c6194bf4119ad3f6da8d4c798c96ff24ef19ebd546eb2d29f69377c0ae3bdc7b"
    }
  },
  {
    "ts": null,
    "headline": "Insulet Corporation Q4 2025 Earnings Call Summary",
    "summary": "Moby summary of Insulet Corporation's Q4 2025 earnings call",
    "url": "https://finnhub.io/api/news?id=0a999952a2a6c11387c4089a36897cb155db0cce2089a8c9ef11cd52e06cc785",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771507800,
      "headline": "Insulet Corporation Q4 2025 Earnings Call Summary",
      "id": 139159351,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "Moby summary of Insulet Corporation's Q4 2025 earnings call",
      "url": "https://finnhub.io/api/news?id=0a999952a2a6c11387c4089a36897cb155db0cce2089a8c9ef11cd52e06cc785"
    }
  },
  {
    "ts": null,
    "headline": "PODD Stock Up on Q4 Earnings & Revenue Beat, Margins Rise",
    "summary": "Insulet jumps after Q4 EPS and revenue beat, margin expansion and record Omnipod growth power a strong 2025 finish and upbeat 2026 outlook.",
    "url": "https://finnhub.io/api/news?id=2cf513552059e3e80ef729a4e85b58fd8826334a11bccf8793e7dee45ae52098",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771506540,
      "headline": "PODD Stock Up on Q4 Earnings & Revenue Beat, Margins Rise",
      "id": 139149208,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "Insulet jumps after Q4 EPS and revenue beat, margin expansion and record Omnipod growth power a strong 2025 finish and upbeat 2026 outlook.",
      "url": "https://finnhub.io/api/news?id=2cf513552059e3e80ef729a4e85b58fd8826334a11bccf8793e7dee45ae52098"
    }
  },
  {
    "ts": null,
    "headline": "Oppenheimer Maintains Outperform on Insulet, Lowers Price Target to $300",
    "summary": "Oppenheimer  analyst Suraj Kalia   maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the price target from $365 to $300.",
    "url": "https://finnhub.io/api/news?id=615aa632478db5ced1b039b5f434999fb79b3b8c077e5f68e36360f2610bee11",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771505585,
      "headline": "Oppenheimer Maintains Outperform on Insulet, Lowers Price Target to $300",
      "id": 139158821,
      "image": "",
      "related": "PODD",
      "source": "Benzinga",
      "summary": "Oppenheimer  analyst Suraj Kalia   maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the price target from $365 to $300.",
      "url": "https://finnhub.io/api/news?id=615aa632478db5ced1b039b5f434999fb79b3b8c077e5f68e36360f2610bee11"
    }
  },
  {
    "ts": null,
    "headline": "Insulet shares are trading lower after multiple analyst firms lowered their respective price targets on the stock.",
    "summary": "Insulet shares are trading lower after multiple analyst firms lowered their respective price targets on the stock.",
    "url": "https://finnhub.io/api/news?id=5198d8a2b4d479ff9e4d954fbcfed134221d007b596afffcfc8fe6ceb58f312d",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771504700,
      "headline": "Insulet shares are trading lower after multiple analyst firms lowered their respective price targets on the stock.",
      "id": 139158822,
      "image": "",
      "related": "PODD",
      "source": "Benzinga",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=5198d8a2b4d479ff9e4d954fbcfed134221d007b596afffcfc8fe6ceb58f312d"
    }
  },
  {
    "ts": null,
    "headline": "JP Morgan Maintains Overweight on Insulet, Lowers Price Target to $340",
    "summary": "JP Morgan  analyst Robbie Marcus   maintains Insulet (NASDAQ:PODD) with a Overweight and lowers the price target from $415 to $340.",
    "url": "https://finnhub.io/api/news?id=1e95389c33bb02dc48a4eb73aa32e2efb171781ad65bf56bff87ed100b9148b8",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771504127,
      "headline": "JP Morgan Maintains Overweight on Insulet, Lowers Price Target to $340",
      "id": 139158823,
      "image": "",
      "related": "PODD",
      "source": "Benzinga",
      "summary": "JP Morgan  analyst Robbie Marcus   maintains Insulet (NASDAQ:PODD) with a Overweight and lowers the price target from $415 to $340.",
      "url": "https://finnhub.io/api/news?id=1e95389c33bb02dc48a4eb73aa32e2efb171781ad65bf56bff87ed100b9148b8"
    }
  },
  {
    "ts": null,
    "headline": "Insulet Q4 Earnings Review: Strong Performance Meets Sky-High Expectations",
    "summary": "Insulet Q4 Earnings Review: Strong Performance Meets Sky-High Expectations",
    "url": "https://finnhub.io/api/news?id=744022134cbb5aed1653c4600e7322d2015fcc37fa9f079ba8bd6991391e824e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771503624,
      "headline": "Insulet Q4 Earnings Review: Strong Performance Meets Sky-High Expectations",
      "id": 139149979,
      "image": "",
      "related": "PODD",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=744022134cbb5aed1653c4600e7322d2015fcc37fa9f079ba8bd6991391e824e"
    }
  },
  {
    "ts": null,
    "headline": "3 Stocks That May Be Trading Below Estimated Value In February 2026",
    "summary": "As February 2026 begins, the U.S. stock market shows a robust start with major indices like the Dow Jones Industrial Average and S&P 500 posting significant gains. In this environment of renewed optimism, identifying stocks that may be trading below their estimated value can offer intriguing opportunities for investors looking to capitalize on potential growth amid favorable market conditions.",
    "url": "https://finnhub.io/api/news?id=173f955aeab584dd0c8693922488925a3c7c4b63ed3cb2dd58821075150e0514",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771501099,
      "headline": "3 Stocks That May Be Trading Below Estimated Value In February 2026",
      "id": 139145299,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "As February 2026 begins, the U.S. stock market shows a robust start with major indices like the Dow Jones Industrial Average and S&P 500 posting significant gains. In this environment of renewed optimism, identifying stocks that may be trading below their estimated value can offer intriguing opportunities for investors looking to capitalize on potential growth amid favorable market conditions.",
      "url": "https://finnhub.io/api/news?id=173f955aeab584dd0c8693922488925a3c7c4b63ed3cb2dd58821075150e0514"
    }
  },
  {
    "ts": null,
    "headline": "Evercore ISI Group Maintains Outperform on Insulet, Lowers Price Target to $340",
    "summary": "Evercore ISI Group  analyst Daniel Markowitz   maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the price target from $370 to $340.",
    "url": "https://finnhub.io/api/news?id=0b365014c755f8181f7b4e80792da7ce4e86acbcfed71e562bfc21a21d0b2e98",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771497423,
      "headline": "Evercore ISI Group Maintains Outperform on Insulet, Lowers Price Target to $340",
      "id": 139158824,
      "image": "",
      "related": "PODD",
      "source": "Benzinga",
      "summary": "Evercore ISI Group  analyst Daniel Markowitz   maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the price target from $370 to $340.",
      "url": "https://finnhub.io/api/news?id=0b365014c755f8181f7b4e80792da7ce4e86acbcfed71e562bfc21a21d0b2e98"
    }
  },
  {
    "ts": null,
    "headline": "Leerink Partners Maintains Outperform on Insulet, Lowers Price Target to $360",
    "summary": "Leerink Partners  analyst Mike Kratky   maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the price target from $386 to $360.",
    "url": "https://finnhub.io/api/news?id=b951088b7546e31ef95f375ca4adc5ddfea6ac63e0525e6ef43d70ee5df0cbec",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771494553,
      "headline": "Leerink Partners Maintains Outperform on Insulet, Lowers Price Target to $360",
      "id": 139146008,
      "image": "",
      "related": "PODD",
      "source": "Benzinga",
      "summary": "Leerink Partners  analyst Mike Kratky   maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the price target from $386 to $360.",
      "url": "https://finnhub.io/api/news?id=b951088b7546e31ef95f375ca4adc5ddfea6ac63e0525e6ef43d70ee5df0cbec"
    }
  },
  {
    "ts": null,
    "headline": "Canaccord Genuity Maintains Buy on Insulet, Lowers Price Target to $435",
    "summary": "Canaccord Genuity  analyst William Plovanic   maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price target from $450 to $435.",
    "url": "https://finnhub.io/api/news?id=0fdb296b6541f0f1a639eaa90d5199a898bddfdc24ab14956d65025d88cc8bbe",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771493254,
      "headline": "Canaccord Genuity Maintains Buy on Insulet, Lowers Price Target to $435",
      "id": 139146009,
      "image": "",
      "related": "PODD",
      "source": "Benzinga",
      "summary": "Canaccord Genuity  analyst William Plovanic   maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price target from $450 to $435.",
      "url": "https://finnhub.io/api/news?id=0fdb296b6541f0f1a639eaa90d5199a898bddfdc24ab14956d65025d88cc8bbe"
    }
  },
  {
    "ts": null,
    "headline": "PODD Q4 Deep Dive: Type 2 Diabetes Expansion and Innovation Drive Outperformance",
    "summary": "Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 31.2% year on year to $783.8 million. The company expects next quarter’s revenue to be around $716.9 million, close to analysts’ estimates. Its non-GAAP profit of $1.55 per share was 6% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=1eded22940e1450e255e7a6a340b9cb528b87c0081f59a054abfc39709571dd1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771479077,
      "headline": "PODD Q4 Deep Dive: Type 2 Diabetes Expansion and Innovation Drive Outperformance",
      "id": 139149304,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 31.2% year on year to $783.8 million. The company expects next quarter’s revenue to be around $716.9 million, close to analysts’ estimates. Its non-GAAP profit of $1.55 per share was 6% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=1eded22940e1450e255e7a6a340b9cb528b87c0081f59a054abfc39709571dd1"
    }
  }
]